An Emerging Role of mTOR in Lipid Biosynthesis

Current Biology

Volumn 19, Issue 22, 2009, Pages

  Laplante, Mathieu ^a,b   Sabatini, David M ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LPIN1 PROTEIN, HUMAN; MAMMALIAN TARGET OF RAPAMYCIN; NUCLEAR PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; SREBF1 PROTEIN, HUMAN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

BIOSYNTHESIS; HUMAN; PHYSIOLOGY; REVIEW;

HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPIDS; NUCLEAR PROTEINS; PPAR GAMMA; PROTEIN-SERINE-THREONINE KINASES; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 70450204007     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2009.09.058     Document Type: Review

References (48)

1. Guertin D.A., and Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 12 (2007) 9-22
2. Alessi D.R., Pearce L.R., and Garcia-Martinez J.M. New insights into mTOR signaling: mTORC2 and beyond. Sci. Signal 2 (2009) pe27
3. Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2 (2001) 282-286
4. Manning B.D., and Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 129 (2007) 1261-1274
5. Porstmann T., Santos C.R., Lewis C., Griffiths B., and Schulze A. A new player in the orchestra of cell growth: SREBP activity is regulated by mTORC1 and contributes to the regulation of cell and organ size. Biochem. Soc. Trans. 37 (2009) 278-283
6. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002) 1125-1131
7. Ferre P., and Foufelle F. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Hormone Res. 68 (2007) 72-82
8. Porstmann T., Griffiths B., Chung Y.L., Delpuech O., Griffiths J.R., Downward J., and Schulze A. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24 (2005) 6465-6481
9. Hegarty B.D., Bobard A., Hainault I., Ferre P., Bossard P., and Foufelle F. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc. Natl. Acad. Sci. USA 102 (2005) 791-796
10. Porstmann T., Santos C.R., Griffiths B., Cully M., Wu M., Leevers S., Griffiths J.R., Chung Y.L., and Schulze A. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8 (2008) 224-236
11. Brown N.F., Stefanovic-Racic M., Sipula I.J., and Perdomo G. The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes. Metabolism 56 (2007) 1500-1507
12. Peng T., Golub T.R., and Sabatini D.M. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol. Cell. Biol. 22 (2002) 5575-5584
13. Mauvoisin D., Rocque G., Arfa O., Radenne A., Boissier P., and Mounier C. Role of the PI3-kinase/mTor pathway in the regulation of the stearoyl CoA desaturase (SCD1) gene expression by insulin in liver. J. Cell Commun. Signal 1 (2007) 113-125
14. Menendez J.A., and Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7 (2007) 763-777
15. Thoreen C.C., Kang S.A., Chang J.W., Liu Q., Zhang J., Gao Y., Reichling L.J., Sim T., Sabatini D.M., and Gray N.S. An ATP-competitive mTOR inhibitor reveals rapamycin-insensitive functions of mTORC1. J. Biol. Chem. 284 (2009) 8023-8032
16. Feldman M.E., Apsel B., Uotila A., Loewith R., Knight Z.A., Ruggero D., and Shokat K.M. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 7 (2009) e38
17. Garcia-Martinez J.M., Moran J., Clarke R.G., Gray A., Cosulich S.C., Chresta C.M., and Alessi D.R. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). Biochem J. (2009) 10.1042/BJ20091035
18. Caldwell S.H., Crespo D.M., Kang H.S., and Al-Osaimi A.M. Obesity and hepatocellular carcinoma. Gastroenterology 127 (2004) S97-103
19. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., and Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115 (2005) 1343-1351
20. Tremblay F., Gagnon A., Veilleux A., Sorisky A., and Marette A. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology 146 (2005) 1328-1337
21. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001) 1167-1174
22. Rosen E.D., and MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell. Biol. 7 (2006) 885-896
23. Cho H.J., Park J., Lee H.W., Lee Y.S., and Kim J.B. Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem. Biophys. Res. Commun. 321 (2004) 942-948
24. Kim J.E., and Chen J. Regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 53 (2004) 2748-2756
25. Bell A., Grunder L., and Sorisky A. Rapamycin inhibits human adipocyte differentiation in primary culture. Obes. Res. 8 (2000) 249-254
26. Gagnon A., Lau S., and Sorisky A. Rapamycin-sensitive phase of 3T3-L1 preadipocyte differentiation after clonal expansion. J. Cell. Physiol. 189 (2001) 14-22
27. El-Chaar D., Gagnon A., and Sorisky A. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 191-198
28. Polak P., Cybulski N., Feige J.N., Auwerx J., Ruegg M.A., and Hall M.N. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab. 8 (2008) 399-410
29. Yeh W.C., Bierer B.E., and McKnight S.L. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc. Natl. Acad. Sci. USA 92 (1995) 11086-11090
30. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.H., Hsu P.P., Bagley A.F., Markhard A.L., and Sabatini D.M. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22 (2006) 159-168
31. Cybulski N., Polak P., Auwerx J., Ruegg M.A., and Hall M.N. mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc. Natl. Acad. Sci. USA 106 (2009) 9902-9907
32. Zhang H.H., Huang J., Duvel K., Boback B., Wu S., Squillace R.M., Wu C.L., and Manning B.D. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS ONE 4 (2009) e6189
33. Le Bacquer O., Petroulakis E., Paglialunga S., Poulin F., Richard D., Cianflone K., and Sonenberg N. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J. Clin. Invest. 117 (2007) 387-396
34. Um S.H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P.R., Kozma S.C., Auwerx J., et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 (2004) 200-205
35. Kim J.B., Wright H.M., Wright M., and Spiegelman B.M. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc. Natl. Acad. Sci. USA 95 (1998) 4333-4337
36. Reue K., and Brindley D.N. Thematic Review Series: Glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism. J. Lipid Res. 49 (2008) 2493-2503
37. Koh Y.K., Lee M.Y., Kim J.W., Kim M., Moon J.S., Lee Y.J., Ahn Y.H., and Kim K.S. Lipin1 is a key factor for the maturation and maintenance of adipocytes in the regulatory network with CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma 2. J. Biol. Chem. 283 (2008) 34896-34906
38. Phan J., Peterfy M., and Reue K. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J. Biol. Chem. 279 (2004) 29558-29564
39. Huffman T.A., Mothe-Satney I., and Lawrence Jr. J.C. Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. Proc. Natl. Acad. Sci. USA 99 (2002) 1047-1052
40. Ntambi J.M., Miyazaki M., Stoehr J.P., Lan H., Kendziorski C.M., Yandell B.S., Song Y., Cohen P., Friedman J.M., and Attie A.D. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. USA 99 (2002) 11482-11486
41. Abu-Elheiga L., Oh W., Kordari P., and Wakil S.J. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc. Natl. Acad. Sci. USA 100 (2003) 10207-10212
42. Toh S.Y., Gong J., Du G., Li J.Z., Yang S., Ye J., Yao H., Zhang Y., Xue B., Li Q., et al. Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice. PLoS ONE 3 (2008) e2890
43. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89 (2004) 2548-2556
44. Jones K.T., Greer E.R., Pearce D., and Ashrafi K. Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1. PLoS Biol. 7 (2009) e60
45. Soukas A.A., Kane E.A., Carr C.E., Melo J.A., and Ruvkun G. Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes Dev. 23 (2009) 496-511
46. Lang F., Bohmer C., Palmada M., Seebohm G., Strutz-Seebohm N., and Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol. Rev. 86 (2006) 1151-1178
47. Aronova S., Wedaman K., Aronov P.A., Fontes K., Ramos K., Hammock B.D., and Powers T. Regulation of ceramide biosynthesis by TOR complex 2. Cell Metab. 7 (2008) 148-158
48. Dickson R.C. Thematic review series: sphingolipids. New insights into sphingolipid metabolism and function in budding yeast. J. Lipid Res. 49 (2008) 909-921